Evidence map›Paper›PMID 36798725›Full record

ArticleAmerican journal of preventive cardiology2023

The role of aldosterone and ideal cardiovascular health in incident diabetes: The Jackson Heart Study.

Veena Kesireddy, Bjorn Kluwe, Neal Pohlman, Songzhu Zhao, Yubo Tan, David Kline, Guy Brock, James B Odei, Valery S Effoe, Justin B Echouffo-Tcheugui and 6 more

Open access · goldAbstract read
In one paragraph

Article in American journal of preventive cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Veena KesireddyDepartment of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States of America.
Bjorn KluweDepartment of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States of America.
Neal PohlmanDepartment of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States of America.
Songzhu ZhaoDepartment of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Yubo TanDepartment of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
David KlineDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem NC 27157, USA.
Guy BrockDepartment of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
James B OdeiDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH 43210, USA.
Valery S EffoeDivision of Cardiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Justin B Echouffo-TcheuguiDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Rita R KalyaniDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Mario SimsDepartment of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Herman A TaylorDivision of Cardiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Morgana Mongraw-ChaffinDepartment of Epidemiology & Prevention, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Ehimare AkhabueDivision of Cardiovascular Diseases and Hypertension, Rutgers University Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
Joshua J JosephDepartment of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States of America.
The Ohio State University Wexner Medical Center · USJohns Hopkins University · USMorehouse School of Medicine · USWake Forest University · USRutgers, The State University of New Jersey · USThe Ohio State University · USUniversity of Mississippi Medical Center · US

Funding

The Role of The Renin-Angiotensin-Aldosterone System, ARMC5, and Neprilysin in Glucose Metabolism among African AmericansK23DK117041 · NIDDK · OHIO STATE UNIVERSITY · PI JOSEPH, JOSHUA J · 2018 to 2022
$1.0M
NHLBI NIH HHS HHSN268201800010INHLBI NIH HHS HHSN268201800011CNHLBI NIH HHS HHSN268201800011INHLBI NIH HHS HHSN268201800012CNHLBI NIH HHS HHSN268201800012INHLBI NIH HHS HHSN268201800014CNHLBI NIH HHS HHSN268201800014INHLBI NIH HHS HHSN268201800015INIDDK NIH HHS K23 DK117041NIMHD NIH HHS HHSN268201800013I
6 · The paper itself

Abstract

Background: Greater attainment of ideal cardiovascular health (ICH) and lower serum aldosterone are associated with lower diabetes risk. Higher levels of ICH are associated with lower aldosterone. The mediational role of aldosterone in the association of ICH with incident diabetes remains unexplored. Thus, we examined the mediational role of aldosterone in the association of 5 ICH components (smoking, diet, physical activity, body mass index [BMI], and cholesterol) with incident diabetes. Additionally, we investigated the mediational role of glucose and blood pressure (BP) in the association of aldosterone with incident diabetes in an African American (AA) cohort. Methods: We conducted a prospective cohort analysis among AA adults, aged 21-94 years, in the Jackson Heart Study. Data on ICH, aldosterone, and cardiometabolic risk factors were collected at exam 1 (2000-2004). Diabetes (fasting glucose ≥ 126 mg/dL, physician diagnosis, use of diabetes drugs, or glycated hemoglobin ≥ 6.5%) was assessed at exams 1 through 3 (2009-2012). ICH metrics were defined by American Heart Association 2020 goals for smoking, dietary intake, physical activity, BMI, total cholesterol, BP and glucose. The number of ICH metrics attained at exam 1, excluding BP and fasting glucose, were summed (0-2, vs. 3+). R Package Results: Among 2,791 participants (mean age: 53±12, 65% female) over a median of 7.5 years, there were 497 incident diabetes cases. Risk of incident diabetes was 37% (HR: 0.63, 95%CI: 0.47, 0.84) lower in 3+ ICH category compared to 0-2 ICH category. Aldosterone mediated 6.98% (95% CI: 1.8%, 18.0%) of the direct effect of ICH on incident diabetes. A 1-unit increase in log-aldosterone was associated with a 44% higher risk of diabetes (HR 1.44, 95%CI 1.25-1.64). BP and glucose mediated 16.3% (95% CI: 7.0%, 31.0%) and 19.7% (95% CI: 6.5%, 34.0%) of the association of aldosterone with incident diabetes, respectively. Conclusion: Aldosterone is a mediator of the association of ICH with incident diabetes, whereas BP and glucose are mediators of the association of aldosterone with incident diabetes, emphasizing the importance of the renin-angiotensin-aldosterone system and ICH in lowering risk of diabetes in AA populations.

Indexed as

African AmericansAldosteroneDiabetesIdeal cardiovascular health

Identifiers

PMID36798725
PMCPMC9926093
OpenAlexW4316362292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.